NHS will not pay for ‘life-changing’ migraine drug

26 September 2019 – BBC News

Erenumab – also known by the name Aimovig – is one of the first bespoke migraine drugs in many years and has been hailed by doctors as a “huge deal“.

Unfortunately the body that approves new drugs said there were doubts whether it was good enough or worth the money so it will not be available on the NHS outside of Scotland.

Current drugs to prevent migraine are former epilepsy or heart failure medicines or the anti-wrinkle drug Botox but some patients have migraines that do not respond to any available treatments.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: